Tumor microbiome linked to immunotherapy success in sarcoma patients

by Stephanie Winn,UC DavisSoft tissue sarcomas intratumoral microbiome at diagnosis may link with prognosis. (A) Representative gross examination of extremity synovial sarcoma specimen; asterisk

Updated on: January 22,2024

Tumor microbiome linked to immunotherapy success in sarcoma patients

by Stephanie Winn,UC DavisSoft tissue sarcomas intratumoral microbiome at diagnosis may link with prognosis. (A) Representative gross examination of extremity synovial sarcoma specimen; asterisk

Updated on:January 22,2024

Study sends strong signal not to sequence immune checkpoint inhibitors in advanced kidney cancer

byDana-Farber Cancer InstituteCredit: Pixabay/CC0 Public DomainPatients with advanced kidney cancer are routinely given immune checkpoint inhibitors (ICIs) as first-line treatment. The CONTACT-0

Updated on: January 22,2024

Study sends strong signal not to sequence immune checkpoint inhibitors in advanced kidney cancer

byDana-Farber Cancer InstituteCredit: Pixabay/CC0 Public DomainPatients with advanced kidney cancer are routinely given immune checkpoint inhibitors (ICIs) as first-line treatment. The CONTACT-0

Updated on:January 22,2024

Cancer drug cooperation could save 1.5 mn lives a year: researchers

Credit: Pixabay/CC0 Public DomainAround 1.5 million lives could be saved every year if the world worked together to more swiftly approve new cancer drugs, researchers said Tuesday.The figure was based

Updated on: February 18,2024

Cancer drug cooperation could save 1.5 mn lives a year: researchers

Credit: Pixabay/CC0 Public DomainAround 1.5 million lives could be saved every year if the world worked together to more swiftly approve new cancer drugs, researchers said Tuesday.The figure was based

Updated on:February 18,2024

Study reveals a trio of immune cells vital in response to liver cancer immunotherapy

by The Mount Sinai HospitalThe study revealed how certain immune cell interactions in tumors facilitate response to checkpoint blockade, pointing to potential new approaches to cancer immunothera

Updated on: February 23,2024

Study reveals a trio of immune cells vital in response to liver cancer immunotherapy

by The Mount Sinai HospitalThe study revealed how certain immune cell interactions in tumors facilitate response to checkpoint blockade, pointing to potential new approaches to cancer immunothera

Updated on:February 23,2024

Researchers pinpoint why lymphoma patients may become resistant to specific therapy

by H. Lee Moffitt Cancer Center & Research InstituteHodgkin lymphoma, nodular lymphocyte predominant (high-power view) Credit: Gabriel Caponetti, MD./Wikipedia/CC BY-SA 3.0With more targeted

Updated on: June 01,2024

Researchers pinpoint why lymphoma patients may become resistant to specific therapy

by H. Lee Moffitt Cancer Center & Research InstituteHodgkin lymphoma, nodular lymphocyte predominant (high-power view) Credit: Gabriel Caponetti, MD./Wikipedia/CC BY-SA 3.0With more targeted

Updated on:June 01,2024

New anti-cancer 'degrader' targets protein essential to infant leukemia

byVan Andel Research InstituteDiscovery of a first-in-class, highly potent VHL-recruiting ENL PROTAC degrader, MS41. Credit:Science Advances(2024). DOI: 10.1126/sciadv.ado1432Scienti

Updated on: September 10,2024

New anti-cancer 'degrader' targets protein essential to infant leukemia

byVan Andel Research InstituteDiscovery of a first-in-class, highly potent VHL-recruiting ENL PROTAC degrader, MS41. Credit:Science Advances(2024). DOI: 10.1126/sciadv.ado1432Scienti

Updated on:September 10,2024

Navigating the maze of cancer: How precision medicine unravels the unknown

by Simon L. April-Monn , Medical XpressPrecision medicine at the forefront. Guided by precision medicine, we pioneer tailored therapies for rare GEP-NENs, leveraging innovative tools to adapt treatmen

Updated on: March 30,2024

Navigating the maze of cancer: How precision medicine unravels the unknown

by Simon L. April-Monn , Medical XpressPrecision medicine at the forefront. Guided by precision medicine, we pioneer tailored therapies for rare GEP-NENs, leveraging innovative tools to adapt treatmen

Updated on:March 30,2024

Simultaneous radiation and immunotherapy found to be beneficial for a subset of lung cancer patients

byUniversity of Chicago Medical CenterAneuploidy and TMB are synergistic predictors of survival following immunotherapy. Credit:Nature Genetics(2022). DOI: 10.1038/s41588-022-01235-4

Updated on: January 07,2024

Simultaneous radiation and immunotherapy found to be beneficial for a subset of lung cancer patients

byUniversity of Chicago Medical CenterAneuploidy and TMB are synergistic predictors of survival following immunotherapy. Credit:Nature Genetics(2022). DOI: 10.1038/s41588-022-01235-4

Updated on:January 07,2024

Study finds 5-year relative survival rate of 59.6 percent in lower-risk myelodysplastic syndromes

by Elana Gotkine HealthDay ReporterAbout 40 percent of patients with lower-risk myelodysplastic syndromes (LR-MDS) die of MDS within five years, according to a study published online Nov. 6 in the&nbs

Updated on: January 23,2024

Study finds 5-year relative survival rate of 59.6 percent in lower-risk myelodysplastic syndromes

by Elana Gotkine HealthDay ReporterAbout 40 percent of patients with lower-risk myelodysplastic syndromes (LR-MDS) die of MDS within five years, according to a study published online Nov. 6 in the&nbs

Updated on:January 23,2024

Early findings suggest clinical and lab-based approach critical to tracking head and neck cancer recurrence

by Anna Megdell,University of MichiganSurvival over time. (A)Median overall survival (mOS) plotted over years of the study. (B)mOS improved from 1998 to 2007 to 2008–2019. (C)m

Updated on: January 30,2024

Early findings suggest clinical and lab-based approach critical to tracking head and neck cancer recurrence

by Anna Megdell,University of MichiganSurvival over time. (A)Median overall survival (mOS) plotted over years of the study. (B)mOS improved from 1998 to 2007 to 2008–2019. (C)m

Updated on:January 30,2024

New study addresses colorectal cancer disparities in Black communities

by Elizabeth Chapin,University of KentuckyCredit: Pixabay/CC0 Public DomainA new University of Kentucky Markey Cancer Center study highlights the need for increased outreach and education to red

Updated on: January 13,2024

New study addresses colorectal cancer disparities in Black communities

by Elizabeth Chapin,University of KentuckyCredit: Pixabay/CC0 Public DomainA new University of Kentucky Markey Cancer Center study highlights the need for increased outreach and education to red

Updated on:January 13,2024

Brain boost: Can a coach help elders at risk for Alzheimer's?

by University of California, San FranciscoCredit: Unsplash/CC0 Public DomainAs more medications move towards federal approval for Alzheimer's disease, a new study led by researchers at UC San

Updated on: April 18,2024

Brain boost: Can a coach help elders at risk for Alzheimer's?

by University of California, San FranciscoCredit: Unsplash/CC0 Public DomainAs more medications move towards federal approval for Alzheimer's disease, a new study led by researchers at UC San

Updated on:April 18,2024